Peng Qinghua met with Babacov, Vice Chairman of Russian State Duma, and Peng Qinghua, Vice Chairman of the National People's Congress Standing Committee (NPCSC), met with Babacov, Vice Chairman of Russian State Duma, in Beijing on the 13th. The two sides indicated that they will jointly implement the important consensus reached by the two heads of state, make good use of the platform of the joint working group of the Sino-Russian Parliamentary Cooperation Committee, deepen exchanges and cooperation between legislative bodies, and promote the further development of China-Russia comprehensive strategic partnership of cooperation in the new era. (Xinhua News Agency)Russian Ministry of Defence: Russian armed forces occupied seven settlements in one week.GCL Technology: It is estimated that there will be no more share repurchase cancellation in 2024. GCL Technology (03800) announced that in view of the fact that the photovoltaic industry is still in excessive competition, in order to ensure the stability of the company's operation and cope with the uncertainty in the future, the company expects that there will be no more share repurchase cancellation in the year ending December 31, 2024.
On December 13th, Jiangsu Securities Regulatory Bureau issued an announcement that Yan Zhen had privately accepted the entrustment of customers to buy and sell securities during his tenure in the securities business department of Xuzhou Jianguo West Road of CITIC Securities (formerly known as the securities business department of Xuzhou Jiefang South Road of CITIC Securities). In violation of regulations, she was supervised to issue a warning letter and recorded it in the integrity file of the securities and futures market.Kexing launched the world's first phase III clinical study of bivalent inactivated enterovirus vaccine. On December 13th, the first volunteer was enrolled in the phase III clinical study of bivalent inactivated enterovirus vaccine developed by Beijing Kexing Biological Products Co., Ltd., a subsidiary of Kexing Holding Biotechnology Co., Ltd. (hereinafter referred to as "Kexing"). The vaccine is used to prevent hand, foot and mouth disease caused by enterovirus 71 (EV71) and coxsackie virus 16 (CA16). A multicenter, randomized, double-blind, controlled study design was adopted in this phase III clinical study to evaluate the protective efficacy, safety and immunogenicity of the vaccine in children aged 6-71 months.Market news: South Korean court issued an arrest warrant to Seoul police chief.
Two States in the United States sued Glock, a gun manufacturer, for ignoring the design flaw that "pistols can easily become machine guns". On the 12th, the prosecutors in New Jersey and Minnesota respectively sued Glock, an Austrian weapons manufacturer, accusing the pistol manufactured by them of design defects and being easily converted into illegal machine guns. According to the complaint, Glock knew this situation for a long time, and continued to sell this pistol to the United States and profit from it, which promoted the proliferation of gun violence in the United States. (Xinhua News Agency)Li Yunze met with Timothy Geithner, Chairman of Huaping Investment Group, USA. Recently, Li Yunze, Party Secretary and Director of State Financial Supervision and Administration, met with TimothyF.Geithner, Chairman of Huaping Investment Group, USA and his party. The two sides exchanged views on the macroeconomic and financial situation, the development prospect of China's financial industry and Huaping's investment and development in China.Market News: Austria provides 1,000 euros to Syrian refugees to help them return home.
Strategy guide 12-14
Strategy guide
12-14
Strategy guide 12-14